Publications by authors named "Holly Alley"

Claim this Profile
V
Validation of histone deacetylase 3 as a therapeutic target in castration-resistant prostate cancer.
Abigail B McLeod, James P Stice, Suzanne E Wardell, Holly M Alley, Ching-Yi Chang

Prostate· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CDK4/6 Therapeutic Intervention and Viable Alternative to Taxanes in CRPC.
James P Stice, Suzanne E Wardell, John D Norris, Alexander P Yllanes, Holly M Alley

Mol Cancer Res· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Androgen receptor antagonism drives cytochrome P450 17A1 inhibitor efficacy in prostate cancer.
John D Norris, Stephanie J Ellison, Jennifer G Baker, David B Stagg, Suzanne E Wardell, Holly M Alley

J Clin Invest· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PIK3CA mutations enable targeting of a breast tumor dependency through mTOR-mediated MCL-1 translation.
Gray R Anderson, Suzanne E Wardell, Merve Cakir, Lorin Crawford, Jim C Leeds, Holly M Alley

Sci Transl Med· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibiting androgen receptor nuclear entry in castration-resistant prostate cancer.
Julie A Pollock, Suzanne E Wardell, Alexander A Parent, David B Stagg, Stephanie J Ellison, Holly M Alley

Nat Chem Biol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of SERD/SERM Hybrid-CDK4/6 Inhibitor Combinations in Models of Endocrine Therapy-Resistant Breast Cancer.
Suzanne E Wardell, Matthew J Ellis, Holly M Alley, Koleen Eisele, Todd VanArsdale

Clin Cancer Res· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the pharmacological activities of RAD1901, a selective estrogen receptor degrader.
Suzanne E Wardell, Erik R Nelson, Christina A Chao, Holly M Alley, Donald P McDonnell

Endocr Relat Cancer· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic identification of signaling pathways with potential to confer anticancer drug resistance.
Colin A Martz, Kathleen A Ottina, Katherine R Singleton, Jeff S Jasper, Suzanne E Wardell, Holly M Alley

Sci Signal· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lysine auxotrophy combined with deletion of the SecA2 gene results in a safe and highly immunogenic candidate live attenuated vaccine for tuberculosis.
Joseph Hinchey, Bo Y Jeon, Holly Alley, Bing Chen, Michael Goldberg

PLoS One· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis